JPRN-UMIN000031451已完成4 期
Study for the effect on blood pressure and heart rate fluctuation by switching from DPP-4 inhibitor to SGLT2 inhibitor Luseogliflozin in patients with type 2 diabetes. - multicenter, prospective, randomized, open-label, parallel group, comparison study - - Luseogliflozin ABPM study
适应症
试验速览
- 阶段
- 4 期
- 状态
- 已完成
- 入组人数
- 68
研究概览
简要总结
暂无简介。
研究设计
- 研究类型
- Interventional
入排标准
- 年龄范围
- 20years-old 至 85years-old(—)
- 性别
- All
入选标准
- 未提供
排除标准
- •1) Patients with taking SGLT2 inhibitors. 2) Hypersensitivity to Luseogliflozin. 3) Uncontrolled diabetic retinopathy 4) Severe liver dysfunction, renal dysfunction, or heart failure 5) Pregnancy, nursing woman or possibly pregnant woman 6) Severe diabetic ketosis, diabetic coma 7) Severe infection, pre and post operation , severe trauma 8) Deficiency of insulin secretion 9) BMI < 22kg/m2 10) eGFR < 30 ml/min 11) Patients with uncontrolled diet therapy. 12) Patients with irregular circadian rhythm. 13) Patients who thought to be inappropriate to enter this study for some reasons by physician's judgments
研究者
相似试验
已完成
不适用
Investigation of the effect on blood pressure improvement by home blood pressure, steps, and sleep time measurementHypertensionJPRN-UMIN000030949Business Development Center, Appliances Company, Panasonic Corporation180
已完成
Unknown
Study on the effect of blood pressure suppression by single intake of test foodsHealthy AdultsJPRN-UMIN000053620Healthcare Systems Co., Ltd.4
招募中
不适用
Effects on Blood Pressure, Cardio-Renal Function and Vascular Endothelial Function by HyperUricemia Treatment StudyHyperuricemiaJPRN-UMIN000007350St. Lukes International Hospital50
已完成
不适用
Study into the control of blood pressure and antihypertensive medication withdrawal in haemodialysis patients by programmed reduction in dry weightCardiovascular: HypertensionCirculatory SystemHypertensionISRCTN12355432Record Provided by the NHSTCT Register - 2005 Update - Department of Health (UK)40
已完成
不适用
The effect of the two drugs( Sodium Thiopental or Ketamine) duration and after ECTCondition 1: Succinylcholine Chloride. Condition 2: Sodium Thiopental. Condition 3: Ketamine.Poisoning: Skeletal muscle relaxants [neuromuscular blocking agents], Skeletal muscle relaxants [neuromuscular blocking agents]Poisoning:Intravenous anaestheticsPoisoning: Other and unspecified general anaestheticsIRCT2016030726950N1Vice Chancellor for Research of Isfahan University Of Medical Sciences64
